Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0U6NJ
|
||||
Former ID |
DNC007303
|
||||
Drug Name |
4-(2-(1H-imidazol-1-yl)ethoxy)-2H-chromen-2-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529860] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H12N2O3
|
||||
Canonical SMILES |
C1=CC=C2C(=C1)C(=CC(=O)O2)OCCN3C=CN=C3
|
||||
InChI |
1S/C14H12N2O3/c17-14-9-13(11-3-1-2-4-12(11)19-14)18-8-7-16-6-5-15-10-16/h1-6,9-10H,7-8H2
|
||||
InChIKey |
MXJNKMWQNZHBOE-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 19 | Target Info | Inhibitor | [529860] | |
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
Reactome | Endogenous sterols | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.